Literature DB >> 24188749

Considerations for the development of a prophylactic vaccine for Acinetobacter baumannii.

Jerónimo Pachón1, Michael J McConnell2.   

Abstract

Entities:  

Keywords:  Acinetobacter baumannii; Antibiotic resistance; Vaccine

Mesh:

Substances:

Year:  2013        PMID: 24188749     DOI: 10.1016/j.vaccine.2013.10.064

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  11 in total

1.  Current advances and challenges in the development of Acinetobacter vaccines.

Authors:  Wangxue Chen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology.

Authors:  Ming-Hsien Chiang; Wang-Chou Sung; Shu-Pei Lien; Ying-Zih Chen; Annie Fei-yun Lo; Jui-Hsin Huang; Shu-Chen Kuo; Pele Chong
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 3.  Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond.

Authors:  Brent S Weber; Christian M Harding; Mario F Feldman
Journal:  J Bacteriol       Date:  2015-12-28       Impact factor: 3.490

4.  A unique antigen against SARS-CoV-2, Acinetobacter baumannii, and Pseudomonas aeruginosa.

Authors:  Mohammad Reza Rahbar; Shaden M H Mubarak; Anahita Hessami; Bahman Khalesi; Navid Pourzardosht; Saeed Khalili; Kobra Ahmadi Zanoos; Abolfazl Jahangiri
Journal:  Sci Rep       Date:  2022-06-27       Impact factor: 4.996

5.  DNA vaccine encoding OmpA and Pal from Acinetobacter baumannii efficiently protects mice against pulmonary infection.

Authors:  Langhuan Lei; Feng Yang; Jintao Zou; Haiming Jing; Jin Zhang; Wanting Xu; Quanming Zou; Jinyong Zhang; Xingyong Wang
Journal:  Mol Biol Rep       Date:  2019-07-24       Impact factor: 2.316

6.  Design of live attenuated bacterial vaccines based on D-glutamate auxotrophy.

Authors:  Maria P Cabral; Patricia García; Alejandro Beceiro; Carlos Rumbo; Astrid Pérez; Miriam Moscoso; Germán Bou
Journal:  Nat Commun       Date:  2017-05-26       Impact factor: 14.919

7.  Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection.

Authors:  Meritxell García-Quintanilla; Marina R Pulido; Jerónimo Pachón; Michael J McConnell
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

Review 8.  The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections.

Authors:  María Guadalupe García-Patiño; Rodolfo García-Contreras; Paula Licona-Limón
Journal:  Front Immunol       Date:  2017-04-12       Impact factor: 8.786

Review 9.  Challenges for Clinical Development of Vaccines for Prevention of Hospital-Acquired Bacterial Infections.

Authors:  Isabelle Bekeredjian-Ding
Journal:  Front Immunol       Date:  2020-08-05       Impact factor: 7.561

10.  Safety and immunogenicity of a new glycoengineered vaccine against Acinetobacter baumannii in mice.

Authors:  Xin Li; Chao Pan; Zhicheng Liu; Peng Sun; Xiaoting Hua; Erling Feng; Yunsong Yu; Jun Wu; Li Zhu; Hengliang Wang
Journal:  Microb Biotechnol       Date:  2021-03-23       Impact factor: 5.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.